SAN FRANCISCO--(BUSINESS WIRE)--The Australian Government has announced an additional A$28 million boost for six pharmaceutical and biotech companies to assist with research and development (R&D) for new drugs into treating debilitating diseases.
The funding comes under the Pharmaceutical Partnerships Program (P3), a scheme designed to stimulate high-value R&D and promote the development of high value partnerships with international firms.
